Atenolol use for infantile hemangiomas

Indian J Dermatol Venereol Leprol. 2021 Mar-Apr;87(2):321. doi: 10.25259/IJDVL_687_19.

Authors

Rosalia Ballona¹, Felipe Velásquez'¹, Iris Kikushima¹, Jean Pierre Zevallos², Jeanette Nuñez³, Consuelo Apagüeño¹

Affiliations

¹ Department of Dermatology, National Children Health Institute, Breña, Lima, Peru.
² Department of Dermatology, Dos de Mayo National Hospital, Lima, Peru.
³ Department of Dermatology, Carlos Alberto Seguin Escobedo National Hospital, Arequipa, Peru.

PMID: 33769740
DOI: 10.25259/IJDVL_687_19

No abstract available

Publication types

Case Reports
Letter
Observational Study

MeSH terms

Adrenergic beta-1 Receptor Antagonists / therapeutic use*
Atenolol / therapeutic use*
Cross-Sectional Studies
Female
Hemangioma / diagnosis*
Hemangioma / drug therapy*
Humans
Infant
Prospective Studies
Skin Neoplasms / diagnosis*
Skin Neoplasms / drug therapy*

Substances

Adrenergic beta-1 Receptor Antagonists
Atenolol